Trials / Completed
CompletedNCT04750369
Enhanced Triage for COVID-19
Enhanced Triage for COVID-19 to Validate the Rapid Acute Lung Injury Diagnostic (RALI-Dx) Test
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 806 (actual)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate of the accuracy of biomarkers (i.e. circulating endothelial and immune activation markers) that indicate progression to severe disease in patients with suspected COVID-19 in the Emergency Department. It is a prospective observational study of patients presenting to emergency departments with a clinical suspicion of COVID19. All participants will have plasma samples collected for biomarker analysis, and will be tested for SARS-CoV-2 infection with a nasopharyngeal swab. Participants will be managed according to the best local practices.
Conditions
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2023-03-23
- Completion
- 2023-03-23
- First posted
- 2021-02-11
- Last updated
- 2023-12-28
Locations
3 sites across 3 countries: Brazil, Canada, Italy
Source: ClinicalTrials.gov record NCT04750369. Inclusion in this directory is not an endorsement.